Das Klinikum

Univ.-Prof. Dr. med. Norbert Stefan

Univ.-Prof. Dr. med. Norbert Stefan

Univ.-Professor for Clinical and Experimental Diabetology

Professorship for Clinical and Experimental Diabetology

Head of the Department of Pathophysiology of
Prediabetes at the Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich

Kontakt

Telefonnummer: 07071 29-85669

E-Mail-Adresse: norbert.stefan@med.uni-tuebingen.de

Klinik / Institut / Zentrum

  • 1997 MD
  • 2006 Specialization Internal Medicine
  • 2007 Senior Physician Internal Medicine (Endocrinology, Diabetology)
  • 2007 PhD
  • 2019 Specialization Endocrinology
  • 1997 Doctoral Thesis
  • 2001-2003 Fellow at the NIH, NIDDK, Phoenix, USA
  • 2006 Assistant Professor
  • 2007 Associate Professor
  • 2007-2011 Heisenberg Stipend from the Deutsche Forschungsgemeinschaft
  • 2011 Full Professor; Heisenberg-Professorship for clinical and experimental Diabetology at the Dept. of Internal Medicine IV, Univ. of Tübingen
  • 2018 Visiting Professor Harvard Medical School, Boston, USA
  • 2001 Silvia-King-Award from the German Diabetes Association
  • 2006 Award of the German Danone Institut für Gesundheit e.V.
  • 2007 Rising Star Award of the European Association for the Study of Diabetes
  • 2007 Adiposity Award of the German Society of Obesity
  • 2008 Hannes Schoberth Award of the German Society of Sports Medicine
  • 2008 Heisenberg Stipendium of the Deutsche Forschungsgemeinschaft
  • 2009 Dr.-Werner-Fekl Award of the German Society of Nutrition
  • 2010 Associate Editor of Diabetologia
  • 2010 Ferdinand-Bertram-Award of the German Diabetes Association
  • 2010 Innovation Award of the German Society for University Medicine
  • 2011 Heisenberg-Professorship for clinical and experimental Diabetology
  • 2012 Executive Board Member of the German Diabetes Association
  • 2014 Advisory Board Member of Diabetologia
  • 2015 Editorial Board Member of Diabetes Care
  • 2015 Editorial Board Member of The Lancet Diabetes & Endocrinology
  • 2015 President of the 50th annual scientific meeting of the German Diabetes Association
  • 2016 Prevention Award of the German Society of Internal Medicine
  • 2017 Werner-Creutzfeldt-Award of the German Diabetes Association
  • 2018 Visiting Professorship Harvard Medical School
  • 2020 Associate Editor of Diabetes
  • 2022 Senior Associate Editor of Diabetes
  • 2022 Glucohead Award Herz- und Diabeteszentrum NRW
  • 2023 Friedrich-Arnold-Gries Award of the German Diabetes Association
  • Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022 Feb 17:S2213-8587(22)00003-1.
  • Wu C et al. Elevated circulating follistatin associates with an increased risk of type 2 diabetes. Nat Commun. 2021 Nov 10;12(1):6486.
  • Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol. 2021 Mar;17(3):135-149.
  • Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020 Jul;8(7):616-627.
  • Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 2020 Jul;16(7):341-342.
  • Eigentler T, Lomberg D, Machann J, Stefan N. Lipodystrophic Nonalcoholic Fatty Liver Disease Induced by Immune Checkpoint Blockade. Ann Intern Med. 2020 Jun 16;172(12):836-837.
  • Stefan N, Häring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019 Apr;7(4):313-324.
  • Stefan N, Häring HU, Schulze MB. Metabolically healthy obesity: the low-hanging fruit in obesity treatment? Lancet Diabetes Endocrinol. 6:249-258, 2018
  • Stefan N, Schick F, Häring HU. Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. Cell Metab. 26:292-300, 2017
  • Stefan N, Ramsauer M, Jordan P, Nowotny B, Kantartzis K, Machann J, Hwang JH, Nowotny P, Kahl S, Harreiter J, Hornemann S, Sanyal AJ, Stewart PM, Pfeiffer AF, Kautzky-Willer A, Roden M, Häring HU, Fürst-Recktenwald S. Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Dabetes Endocrinol. 2:406-416, 2014
  • Stefan N, Schick F, Häring HU. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014 Dec 4;371(23):2236-7.
  • Stefan N, Häring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 1:152-162, 2013
  • Stefan N, Häring HU. Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med. 19:394-395, 2013
  • Stefan N, Häring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol. 9:144-152, 2013
  • Lehmann R, Franken H, Dammeier S, Rosenbaum L, Kantartzis K, Peter A, Zell A, Adam P, Li J, Xu G, Königsrainer A, Machann J, Schick F, Hrabé de Angelis M, Schwab M, Staiger H, Schleicher E, Gastaldelli A, Fritsche A, Häring HU, Stefan N. Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care. 36:2331-2338, 2013
  • Stefan N, Häring HU. The metabolically benign and malignant fatty liver. Diabetes. 60:2011-2017, 2011
  • Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, Königsrainer A, Königsrainer I, Kröber S, Niess A, Fritsche A, Häring HU, Stefan N. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut. 58:1281-1288, 2009
  • Stefan N, Schick F, Häring HU. Sex hormone-binding globulin and risk of type 2 diabetes. N. Engl. J. Med. 361:2675-2676, 2009
  • Häring HU. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 168:1609-1616, 2008
  • Publikationen
  • Deutsche Diabetes Gesellschaft
  • Deutsche Gesellschaft für Innere Medizin
  • European Association for the Study of Diabetes